InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
38%
T+90 mean return
-14.9%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by CONLEY SHERYL L, Director. Insider active across 4 companies, notably Surgalign Holdings, INC.. Cumulatively, 19 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €142k. History available since 7 May 2021. The latest transaction was filed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
10,402 sharesCommon StockSEC:0001193125-26-279535:0
30,000 shares0Common StockSEC:0001238659-26-000002:0
14,164 shares0Common StockSEC:0001171843-25-004064:0
44,444 shares@ US$2.2540.3% of flowCommon StockSEC:0000950170-25-017198:0
5,771 shares0Common StockSEC:0001171843-24-003904:0
25,000 sharesCommon StockSEC:0000950170-24-069573:0
6,500 shares0Common StockSEC:0001171843-23-003957:0
36,364 sharesCommon StockSEC:0001062993-23-012472:0
22,857 shares0Common StockSEC:0001209191-22-046161:0
7,954 shares0Common StockSEC:0001171843-22-004298:0
38,910 sharesCommon StockSEC:0001062993-22-013870:0
8,179 shares0Common StockSEC:0001171843-21-007368:0
8,179 shares0Common StockSEC:0001171843-21-007368
6,200 shares@ US$14.0330.075% mcap50.0% of flowCommon StockSEC:0001062993-21-005379:0
6,200 shares@ US$14.03329.8% of flowCommon StockSEC:0001062993-21-005379
7,137 sharesCommon StockSEC:0001062993-21-005246:0
7,137 sharesCommon StockSEC:0001062993-21-005246
57,803 shares0Common StockSEC:0001209191-21-031353
57,803 shares0Common StockSEC:0001209191-21-031353:0
19 of 19 declarations
About CONLEY SHERYL L
Sheryl L. Conley is a Board Member at Surgalign Holdings, Inc., Neuronetics, Inc., and Anika Therapeutics, Inc. She brings her expertise in governance and strategy to the boards of these companies. Her role involves overseeing operations and contributing to strategic decision-making that fosters growth and innovation. With a strong background in the healthcare sector, she is well-positioned to guide these companies through market challenges.
